| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |